Name: 글로벌 시장 동향
SKU: MD7197
Availability: InStock

보고서 요약(국문)

개요
전 세계 심혈관 초음파 시스템 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
심혈관 초음파 시스템(심장 초음파 검사 시스템)은 인체 내 심장과 혈관을 비침습적으로 평가하고 시각화하는 데 사용되는 의료 영상 장치입니다. 이 시스템은 고주파 음파(초음파)를 이용하여 심장의 구조, 기능 및 혈류 패턴에 대한 실시간 이미지와 비디오를 생성합니다. 이 기술은 심장 판막 질환, 선천성 심장 결함, 심근 질환, 혈관 이상 등 다양한 심혈관 질환을 진단하고 모니터링하는 데 필수적입니다.
심장 초음파 검사는 갈비뼈 사이에 들어갈 수 있는 작은 크기의 저주파 프로브를 심장 설정으로 사용하여 수행해야 합니다. 초음파는 20,000Hz 이상의 주파수로 정의됩니다. 초음파 프로브는 환자가 듣거나 느끼지 못하는 음파를 인체에 전달합니다. 음파가 내부 구조물에 부딪혀 반사되면, 기술은 되돌아오는 음파의 "메아리"를 해석하여 환자의 심장 움직임을 실시간으로 재구성합니다.
시장 동향: 성장 동력
첨단 심혈관 초음파 시스템에 대한 수요 증가
첨단 심혈관 초음파 시스템에 대한 수요 증가는 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 이러한 첨단 시스템에는 최소 침습 시술을 통해 환자 결과를 개선하는 데 기여하는 인공지능(AI) 기능이 포함되어 있습니다. 이러한 첨단 시스템은 의료진이 더 빠르고 반복 가능한 검사를 수행할 수 있도록 지원합니다.
예를 들어, 지멘스 헬스케어는 2023년 8월 25일, 새롭고 강력한 인공지능(AI) 기능을 탑재한 심혈관 전용 초음파 시스템인 아쿠손 오리진(Acuson Origin)을 출시했습니다. 환자 결과를 개선하고 의사가 최소 침습 심장 시술을 더욱 효율적으로 수행할 수 있도록 설계된 아쿠손 오리진은 진단, 구조적 심장, 전기생리학적, 소아 시술을 포함한 심혈관 환자 치료의 모든 영역을 포괄합니다.

또한, 2020년 10월 12일 GE Healthcare는 인공지능(AI) 기반의 새로운 기능을 통해 의료진이 더욱 빠르고 일관성 있는 검사를 수행할 수 있도록 지원하는 Vivid 심혈관 초음파 시스템용 Ultra Edition 패키지에 대해 미국 FDA 510k 승인을 획득했습니다.
더욱이, 초음파 기술의 지속적인 발전으로 더욱 발전되고 정교한 심혈관 초음파 시스템이 개발되었습니다. 이러한 시스템은 향상된 화질, 진단 정확도, 그리고 3D 및 4D 영상, 변형 영상, 조영 증강 영상과 같은 향상된 기능을 제공합니다. 이러한 혁신을 통해 심혈관 질환을 더욱 효과적으로 진단하고 치료할 수 있게 되었습니다.
예를 들어, 2023년 1월 22일 필립스는 차세대 소형 휴대용 심혈관 초음파 솔루션인 Compact 5000 시리즈를 전 세계에 출시했습니다. 이 새로운 초음파 장비는 화질이나 성능 저하 없이 휴대성과 다용성을 고려하여 설계되었으며, 고급 카트형 초음파 시스템에서나 볼 수 있는 수준의 진단 품질을 더 많은 환자에게 제공하는 것을 목표로 합니다.
또한, 이러한 첨단 장비는 향상된 화질과 편의성을 제공합니다. 예를 들어, 글로벌 의료기기 회사이자 삼성전자 계열사인 삼성메디슨은 2021년 9월 30일, 모든 의료 전문가에게 향상된 화질, 사용 편의성 및 편리성을 제공하는 새로운 프리미엄 심장 초음파 시스템인 V8을 출시했습니다.
또한, 심혈관 질환의 유병률 증가, FDA 승인 건수 증가, 비침습적 진단 방법에 대한 수요 증가, 인식 제고 및 새로운 시스템 개발의 기술 발전은 예측 기간 동안 시장 성장을 견인할 것으로 예상되는 요인입니다.
제약 요인
기계 관련 합병증, 심혈관 초음파 시스템의 높은 가격, 숙련된 전문가 부족 등의 요인이 시장 성장을 저해할 것으로 예상됩니다.
세분화 분석
글로벌 심혈관 초음파 시스템 시장은 유형, 기술, 휴대성, 최종 사용자 및 지역별로 세분화됩니다.
경식도 심초음파(TEE) 부문은 심혈관 초음파 시스템 시장 점유율의 약 46.2%를 차지했습니다.
경식도 심초음파 부문은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 경식도 심초음파는 다른 검사로는 충분히 시각화하기 어려운 질환을 진단하는 데 유용하며, 감염성 심내막염, 대동맥 박리 또는 복잡한 판막 질환이 의심되는 경우에 자주 사용됩니다. 경식도 심초음파 시스템은 주로 많은 심혈관 질환 환자의 치료 관리 및 지침에 사용됩니다.
예를 들어, 2022년 6월 30일, 클라리우스 모바일 헬스(Clarius Mobile Health)와 이마코(ImaCor Inc.)는 파트너십을 발표하고 중환자실(ICU)에서 가장 위중한 환자의 치료 관리 및 지침을 위해 설계된 휴대용 경식도 심초음파(TEE) 시스템을 출시했습니다.
또한, 경식도 심초음파는 심장의 구조와 기능을 자세히 보여주며, 다양한 심혈관 질환의 진단 및 관리에 도움을 줄 수 있습니다. 경식도 심초음파는 여러 질환의 진단 및 관리에 사용됩니다.

2022년 5월, 필립스는 심장 중재 시술용 초음파 시스템인 EchoNavigator 4.0, EPIQ CVXi를 국제적으로 출시한다고 발표했습니다. 심장 가까이에 초음파 변환기를 위치시키는 실시간 경식도 심초음파(TEE)와 X선 투시를 통합한 EchoNavigator 4.0은 심장 판막 복구 또는 교체와 같은 복잡한 구조적 심장 질환 치료의 결정, 안내, 치료 및 확인을 지원합니다.
지역 분석
북미는 시장 점유율의 약 39.2%를 차지했습니다.
북미 지역은 주요 업체들의 강력한 입지와 기술 발전으로 인해 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 특히 미국은 제약 회사 및 의료 기기 회사와 같은 주요 업체들의 강력한 입지로 잘 알려져 있습니다. 주요 업체들이 활발한 연구 활동을 펼치면서 더욱 향상된 기능을 갖춘 첨단 심혈관 초음파 시스템이 출시되고 있습니다.

예를 들어, 2023년 8월 25일 GE 헬스케어는 의료진이 진단 및 치료 결정을 신속하게 내릴 수 있도록 현장에서 심장 및 혈관을 신속하게 평가할 수 있도록 설계된 휴대용 무선 초음파 영상 시스템인 Vscan Air SL을 출시했습니다. Vscan 제품군의 최신 제품인 Vscan Air SL은 GE 헬스케어의 독자적인 SignalMax 및 XDclear 기술을 탑재하여 업계 최고 수준의 단일 결정 트랜스듀서 기술과 함께 높은 침투력, 해상도 및 감도를 제공합니다.
또한, 이 지역의 기술 발전 역시 중요한 요인입니다. 북미에는 의료 산업과 협력하는 여러 대학 및 연구 기관이 있습니다. 이러한 협력을 통해 기술적으로 혁신적인 심혈관 초음파 시스템이 개발되고, 그 이점에 대한 지식이 향상되어 이 지역에서 시장을 선도하고 있습니다.

경쟁 환경
심혈관 초음파 시스템 시장의 주요 글로벌 업체로는 Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare, Hitachi, Ltd., CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, SAMSUNG HEALTHCARE, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., FUJIFILM Holdings Corporation, Whale Imaging Inc. 등이 있습니다.
주요 개발 사항
• 2023년 6월 23일, 인공지능 기술을 통해 심장 영상 분야를 혁신하는 디지털 헬스 선도 기업 UltraSight는 현장 초음파 혁신 기업 EchoNous와의 파트너십을 발표했습니다. 이 파트너십을 통해 더 많은 의료 전문가들이 심장 초음파 검사를 수행하고 환자의 심장 치료 접근성을 높일 수 있게 됩니다. 이번 협력 발표는 심장 초음파 전문가들이 한자리에 모이는 최고의 행사인 ASE 2023에서 이루어졌습니다.

• 최첨단 현장 초음파(POCUS) 솔루션 개발 전문 기업이자 후지필름 헬스케어 포트폴리오의 일원인 후지필름 소노사이트(FUJIFILM Sonosite, Inc.)는 2023년 1월 27일 새로운 소노사이트 PX 초음파 시스템을 출시했습니다. 소노사이트 PX는 소노사이트 시스템 사상 최고 수준의 영상 선명도, 워크플로우 효율성 향상 기능, 그리고 적응형 폼팩터를 갖춘 차세대 소노사이트 POCUS 시스템입니다.
• 2022년 4월, 후지필름 소노사이트는 임상 현장에서 경식도 초음파(TEU)를 활용할 수 있도록 지원하는 새로운 T8-3 경식도 초음파 변환기와 심폐소생술 검사 유형을 출시했습니다.

COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 심혈관 초음파 시스템 시장에 상당한 영향을 미쳤습니다. 팬데믹 초기에는 많은 의료기관에서 심혈관 초음파와 같은 비응급 심장 영상 검사를 포함한 선택적 의료 시술을 연기하거나 취소했습니다. 이로 인해 심혈관 초음파 시스템에 대한 수요가 일시적으로 감소했습니다. 또한 팬데믹은 전 세계적으로 이러한 장비의 공급망에 차질을 초래했습니다.
보고서 구매 이유:

• 유형, 기술, 최종 사용자 및 지역별 글로벌 심혈관 초음파 시스템 시장 세분화를 시각화하고 주요 상업 자산 및 플레이어를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별합니다.
• 모든 세그먼트를 포함한 심혈관 초음파 시스템 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 포함된 PDF 보고서를 제공합니다.

• 주요 플레이어의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 심혈관 초음파 시스템 시장 보고서는 약 69개의 표, 71개의 그림, 188페이지로 구성됩니다.
대상 고객 (2023년)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global cardiovascular ultrasound system market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.
A cardiovascular ultrasound system also known as an echocardiography system is a medical imaging device used for non-invasive assessment and visualization of the heart and blood vessels within the body. It employs high-frequency sound waves (ultrasound) to create real-time images and videos of the heart's structure, function, and blood flow patterns. This technology is essential for diagnosing and monitoring various cardiovascular conditions, such as heart valve diseases, congenital heart defects, heart muscle disorders, vascular abnormalities and others.
Cardiac ultrasound should be performed with a low-frequency probe that has a small footprint that can fit between the ribs, using a cardiac setting. Ultrasound is defined as a frequency greater than 20,000 Hertz (Hz). The ultrasound probe sends sound waves, which the patient does not hear or feel, through the body. When the sound waves bounce off internal structures, the technology interprets the "echos" of the returning waves and reconstructs a moving picture of the patient’s heart in real-time.
Market Dynamics: Drivers
Increasing demand for advanced cardiovascular ultrasound systems
The increasing demand for advanced cardiovascular ultrasound systems is expected to drive the market over the forecast period. The advanced systems include artificial intelligence features that are responsible for better patient outcomes by performing minimally invasive procedures. These advanced systems helps to enable clinicians to acquire faster and more repeatable tests.
For instance, on August 25, 2023, Siemens Healthineers launched the Acuson Origin, a dedicated cardiovascular ultrasound system with new, robust artificial intelligence (AI) features. Designed to improve patient outcomes and help physicians perform minimally invasive cardiac procedures more efficiently, the Acuson Origin addresses the entire continuum of cardiovascular patient care, including diagnostic, structural heart, electrophysiological, and pediatric procedures.
Additionally, on October 12, 2020, GE Healthcare released U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.
Moreover, ongoing advancements in ultrasound technology have led to the development of more advanced and sophisticated cardiovascular ultrasound systems. These systems offer higher image quality, improved diagnostic accuracy, and enhanced features such as 3D and 4D imaging, strain imaging, and contrast-enhanced imaging. These innovations make it easier to diagnose and treat cardiovascular conditions effectively.
For instance, on January 22, 2023, Philips launched globally their next-generation compact cardiovascular portable ultrasound solution, the Compact 5000 Series. This new ultrasound is designed for portability and versatility without compromising image quality or performance and aims to bring the diagnostic quality associated with premium cart-based ultrasound systems to more patients.
In addition, the advanced devices helps to provide enhanced image quality and convenience. For instance, on September 30, 2021, Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, introduced the V8, a new premium cardiology ultrasound system that provides enhanced image quality, usability, and convenience for all medical professionals.
Further, the increasing prevalence of cardiovascular conditions, rising FDA approvals, rising demand for non-invasive diagnostic methods, increasing awareness and technological advancements in the development of novel systems are the factors expected to drive the market over the forecast period.
Restraints
Factors such as complications associated with the machines, the high cost of the cardiovascular ultrasound systems and lack of trained professionals are expected to hamper the market.
Segment Analysis
The global cardiovascular ultrasound system market is segmented based on type, technology, portability, end-user and region.
The transesophageal echocardiogram segment accounted for approximately 46.2% of the cardiovascular ultrasound system market share
The transesophageal echocardiogram segment is expected to hold the largest market share over the forecast period. A transesophageal echocardiogram is valuable for diagnosing conditions that may not be adequately visualized with other tests, and it is often used in cases of suspected infective endocarditis, aortic dissection, or complex valve pathology. The transesophageal echocardiography system is mainly used to manage and guide care for many cardiovascular patients.
For instance, on June 30, 2022, Clarius Mobile Health and ImaCor Inc. announced a partnership and launched a handheld transesophageal echocardiography (TEE) system designed to manage and guide care for the most critically ill patients in the Intensive Care Unit (ICU).
Moreover, a transesophageal echocardiogram shows a detailed view of the heart’s structure and function. It can help diagnose and manage many different cardiovascular conditions. The transesophageal echocardiogram uses transesophageal echocardiography for the diagnosis and management of many diseases.
In May 2022, Philips announced the international launch of EchoNavigator 4.0, EPIQ CVXi interventional cardiology ultrasound system. By integrating real-time transoesophageal echocardiography (TEE), which places the ultrasound transducer close to the heart, and X-ray fluoroscopy, EchoNavigator 4.0 helps interventional teams to decide, guide, treat, and confirm complex structural heart disease therapy, such as heart valve repair or replacement.
Geographical Analysis
North America accounted for approximately 39.2% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and technological advancements. North America especially the United States is very well known for its strong presence of major players such as pharmaceutical companies and medical device companies. The presence of major players actively performing in research activities, leads to the launch of advanced cardiovascular ultrasound systems with better features.
For instance, on August 25, 2023, GE HealthCare launched the Vscan Air SL, a handheld, wireless ultrasound imaging system designed for rapid cardiac and vascular assessments at the point of care to help clinicians accelerate diagnoses and treatment decisions. The latest addition to the Vscan product suite, Vscan Air SL features GE HealthCare’s proprietary SignalMax and XDclear technology that provide high levels of penetration, resolution, and sensitivity in imaging performance with an industry-leading single crystal transducer technology.
Furthermore, the technological advancements in the region is also a considerable factor in the region. North America is home to several universities and research institutions that collaborate with the healthcare industry. These collaborations lead to the development of technologically innovative cardiovascular ultrasound systems, which increases the knowledge about their benefits, leading to market dominance in the region.
Competitive Landscape
The major global players in the cardiovascular ultrasound system market include Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare, Hitachi, Ltd., CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, SAMSUNG HEALTHCARE, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., FUJIFILM Holdings Corporation, Whale Imaging Inc. and among others.
Key Developments
• On June 23, 2023, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, released the announcement about the partnership with point-of-care ultrasound innovator EchoNous, to enable more healthcare professionals to perform cardiac ultrasound and help increase patient access to cardiac care. The new collaboration was announced at ASE 2023, the premier event for bringing together echo professionals.
• On January 27, 2023, FUJIFILM Sonosite, Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, launched the new Sonosite PX ultrasound system. Sonosite PX is the next generation in Sonosite POCUS, with the most advanced image clarity ever seen in a Sonosite system, a suite of workflow efficiency features, and an adaptable form factor.
• In April 2022, FUJIFILM Sonosite, Inc. launched a new T8-3 transesophageal transducer and Cardiac Resuscitation exam type, to assist clinicians in using transesophageal ultrasound (TEU) at the point of care.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global cardiovascular ultrasound system market. During the early stages of the pandemic, many healthcare facilities postponed or canceled elective medical procedures, including non-urgent cardiac imaging tests such as cardiovascular ultrasounds. This led to a temporary decline in the demand for cardiovascular ultrasound systems. The pandemic also disrupted the supply chain of these devices globally.
Why Purchase the Report?
• To visualize the global cardiovascular ultrasound system market segmentation based on type, technology, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of cardiovascular ultrasound system market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global cardiovascular ultrasound system market report would provide approximately 69 tables, 71 figures, and 188 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Technology
3.3. Snippet by Portability
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Demand for Advanced Cardiovascular Ultrasound Systems
4.1.2. Restraints
4.1.2.1. High Cost of the Equipment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Stress Echocardiogram*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Transesophageal Echocardiogram
7.4. Transthoracic Echocardiogram
7.5. Contrast Echocardiogram
7.6. Doppler Echocardiogram
7.7. Others
8. By Technology
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. 2D Ultrasound*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. 3D Ultrasound
8.4. 4D Ultrasound
8.5. Others
9. By Portability
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
9.1.2. Market Attractiveness Index, By Portability
9.2. Portable*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Handheld
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Cardiovascular Diagnostic Centers
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.6.1. U.S.
11.2.6.2. Canada
11.2.6.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.6.1. Germany
11.3.6.2. UK
11.3.6.3. France
11.3.6.4. Italy
11.3.6.5. Spain
11.3.6.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.6.1. Brazil
11.4.6.2. Argentina
11.4.6.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.6.1. China
11.5.6.2. India
11.5.6.3. Japan
11.5.6.4. Australia
11.5.6.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Siemens Healthineers AG*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Koninklijke Philips N.V.
13.3. GE HealthCare
13.4. Hitachi, Ltd.
13.5. CANON MEDICAL SYSTEMS CORPORATION
13.6. ESAOTE SPA
13.7. SAMSUNG HEALTHCARE
13.8. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
13.9. FUJIFILM Holdings Corporation
13.10. Whale Imaging Inc.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Siemens Healthineers AG, 4. Key Developments, Koninklijke Philips N.V., GE HealthCare, Hitachi, Ltd., CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, SAMSUNG HEALTHCARE, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., FUJIFILM Holdings Corporation, Whale Imaging Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Cardiovascular Ultrasound System Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Cardiovascular Ultrasound System Market Value, By Technology, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Cardiovascular Ultrasound System Market Value, By Portability, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Cardiovascular Ultrasound System Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Cardiovascular Ultrasound System Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Cardiovascular Ultrasound System Market Value, By Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Cardiovascular Ultrasound System Market Value, By Type, 2021-2030 (US$ Million)

Table 8 Global Cardiovascular Ultrasound System Market Value, By Technology, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Cardiovascular Ultrasound System Market Value, By Technology, 2021-2030 (US$ Million)

Table 10 Global Cardiovascular Ultrasound System Market Value, By Portability, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Cardiovascular Ultrasound System Market Value, By Portability, 2021-2030 (US$ Million)

Table 12 Global Cardiovascular Ultrasound System Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Cardiovascular Ultrasound System Market Value, By End-User, 2021-2030 (US$ Million)

Table 14 Global Cardiovascular Ultrasound System Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Cardiovascular Ultrasound System Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Cardiovascular Ultrasound System Market Value, By Type, 2021-2030 (US$ Million)

Table 17 North America Cardiovascular Ultrasound System Market Value, By Technology, 2021-2030 (US$ Million)

Table 18 North America Cardiovascular Ultrasound System Market Value, By Portability, 2021-2030 (US$ Million)

Table 19 North America Cardiovascular Ultrasound System Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 North America Cardiovascular Ultrasound System Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Cardiovascular Ultrasound System Market Value, By Type, 2021-2030 (US$ Million)

Table 22 South America Cardiovascular Ultrasound System Market Value, By Technology, 2021-2030 (US$ Million)

Table 23 South America Cardiovascular Ultrasound System Market Value, By Portability, 2021-2030 (US$ Million)

Table 24 South America Cardiovascular Ultrasound System Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 South America Cardiovascular Ultrasound System Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Cardiovascular Ultrasound System Market Value, By Type, 2021-2030 (US$ Million)

Table 27 Europe Cardiovascular Ultrasound System Market Value, By Technology, 2021-2030 (US$ Million)

Table 28 Europe Cardiovascular Ultrasound System Market Value, By Portability, 2021-2030 (US$ Million)

Table 29 Europe Cardiovascular Ultrasound System Market Value, By End-User, 2021-2030 (US$ Million)

Table 30 Europe Cardiovascular Ultrasound System Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Cardiovascular Ultrasound System Market Value, By Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Cardiovascular Ultrasound System Market Value, By Technology, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Cardiovascular Ultrasound System Market Value, By Portability, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Cardiovascular Ultrasound System Market Value, By End-User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Cardiovascular Ultrasound System Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Cardiovascular Ultrasound System Market Value, By Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Cardiovascular Ultrasound System Market Value, By Technology, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Cardiovascular Ultrasound System Market Value, By Portability, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Cardiovascular Ultrasound System Market Value, By End-User, 2021-2030 (US$ Million)

Table 40 Siemens Healthineers AG: Overview

Table 41 Siemens Healthineers AG: Product Portfolio

Table 42 Siemens Healthineers AG: Key Developments

Table 43 Koninklijke Philips N.V.: Overview

Table 44 Koninklijke Philips N.V.: Product Portfolio

Table 45 Koninklijke Philips N.V.: Key Developments

Table 46 GE HealthCare: Overview

Table 47 GE HealthCare: Product Portfolio

Table 48 GE HealthCare: Key Developments

Table 49 Hitachi, Ltd.: Overview

Table 50 Hitachi, Ltd.: Product Portfolio

Table 51 Hitachi, Ltd.: Key Developments

Table 52 CANON MEDICAL SYSTEMS CORPORATION: Overview

Table 53 CANON MEDICAL SYSTEMS CORPORATION: Product Portfolio

Table 54 CANON MEDICAL SYSTEMS CORPORATION: Key Developments

Table 55 ESAOTE SPA: Overview

Table 56 ESAOTE SPA: Product Portfolio

Table 57 ESAOTE SPA: Key Developments

Table 58 SAMSUNG HEALTHCARE: Overview

Table 59 SAMSUNG HEALTHCARE: Product Portfolio

Table 60 SAMSUNG HEALTHCARE: Key Developments

Table 61 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Overview

Table 62 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Product Portfolio

Table 63 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Key Developments

Table 64 FUJIFILM Holdings Corporation: Overview

Table 65 FUJIFILM Holdings Corporation: Product Portfolio

Table 66 FUJIFILM Holdings Corporation: Key Developments

Table 67 Whale Imaging Inc.: Overview

Table 68 Whale Imaging Inc.: Product Portfolio

Table 69 Whale Imaging Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 2 Global Cardiovascular Ultrasound System Market Share, By Type, 2022 & 2030 (%)

Figure 3 Global Cardiovascular Ultrasound System Market Share, By Technology, 2022 & 2030 (%)

Figure 4 Global Cardiovascular Ultrasound System Market Share, By Portability, 2022 & 2030 (%)

Figure 5 Global Cardiovascular Ultrasound System Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Cardiovascular Ultrasound System Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Cardiovascular Ultrasound System Market Y-o-Y Growth, By Type, 2022-2030 (%)

Figure 8 Stress Echocardiogram Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 9 Transesophageal Echocardiogram Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 10 Transthoracic Echocardiogram Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 11 Contrast Echocardiogram Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 12 Doppler Echocardiogram Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 13 Others Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 14 Global Cardiovascular Ultrasound System Market Y-o-Y Growth, By Technology, 2022-2030 (%)

Figure 15 2D Ultrasound Technology in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 16 3D Ultrasound Technology in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 17 4D Ultrasound Technology in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 18 Others Technology in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 19 Global Cardiovascular Ultrasound System Market Y-o-Y Growth, By Portability, 2022-2030 (%)

Figure 20 Portable Portability in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 21 Handheld Portability in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 22 Global Cardiovascular Ultrasound System Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 23 Hospitals End-User in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 24 Specialty Clinics End-User in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 25 Cardiovascular Diagnostic Centers End-User in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 26 Others End-User in Global Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 27 Global Cardiovascular Ultrasound System Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 28 North America Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 29 Asia-Pacific Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 30 Europe Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 31 South America Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 32 Middle East and Africa Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 33 North America Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 34 North America Cardiovascular Ultrasound System Market Share, By Type, 2022 & 2030 (%)

Figure 35 North America Cardiovascular Ultrasound System Market Share, By Technology, 2022 & 2030 (%)

Figure 36 North America Cardiovascular Ultrasound System Market Share, By Portability, 2022 & 2030 (%)

Figure 37 North America Cardiovascular Ultrasound System Market Share, By End-User, 2022 & 2030 (%)

Figure 38 North America Cardiovascular Ultrasound System Market Share, By Country, 2022 & 2030 (%)

Figure 39 South America Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 40 South America Cardiovascular Ultrasound System Market Share, By Type, 2022 & 2030 (%)

Figure 41 South America Cardiovascular Ultrasound System Market Share, By Technology, 2022 & 2030 (%)

Figure 42 South America Cardiovascular Ultrasound System Market Share, By Portability, 2022 & 2030 (%)

Figure 43 South America Cardiovascular Ultrasound System Market Share, By End-User, 2022 & 2030 (%)

Figure 44 South America Cardiovascular Ultrasound System Market Share, By Country, 2022 & 2030 (%)

Figure 45 Europe Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 46 Europe Cardiovascular Ultrasound System Market Share, By Type, 2022 & 2030 (%)

Figure 47 Europe Cardiovascular Ultrasound System Market Share, By Technology, 2022 & 2030 (%)

Figure 48 Europe Cardiovascular Ultrasound System Market Share, By Portability, 2022 & 2030 (%)

Figure 49 Europe Cardiovascular Ultrasound System Market Share, By End-User, 2022 & 2030 (%)

Figure 50 Europe Cardiovascular Ultrasound System Market Share, By Country, 2022 & 2030 (%)

Figure 51 Asia-Pacific Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 52 Asia-Pacific Cardiovascular Ultrasound System Market Share, By Type, 2022 & 2030 (%)

Figure 53 Asia-Pacific Cardiovascular Ultrasound System Market Share, By Technology, 2022 & 2030 (%)

Figure 54 Asia-Pacific Cardiovascular Ultrasound System Market Share, By Portability, 2022 & 2030 (%)

Figure 55 Asia-Pacific Cardiovascular Ultrasound System Market Share, By End-User, 2022 & 2030 (%)

Figure 56 Asia-Pacific Cardiovascular Ultrasound System Market Share, By Country, 2022 & 2030 (%)

Figure 57 Middle East & Africa Cardiovascular Ultrasound System Market Value, 2021-2030 (US$ Million)

Figure 58 Middle East & Africa Cardiovascular Ultrasound System Market Share, By Type, 2022 & 2030 (%)

Figure 59 Middle East & Africa Cardiovascular Ultrasound System Market Share, By Technology, 2022 & 2030 (%)

Figure 60 Middle East & Africa Cardiovascular Ultrasound System Market Share, By Portability, 2022 & 2030 (%)

Figure 61 Middle East & Africa Cardiovascular Ultrasound System Market Share, By End-User, 2022 & 2030 (%)

Figure 62 Siemens Healthineers AG: Financials

Figure 63 Koninklijke Philips N.V.: Financials

Figure 64 GE HealthCare: Financials

Figure 65 Hitachi, Ltd.: Financials

Figure 66 CANON MEDICAL SYSTEMS CORPORATION: Financials

Figure 67 ESAOTE SPA: Financials

Figure 68 SAMSUNG HEALTHCARE: Financials

Figure 69 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Financials

Figure 70 FUJIFILM Holdings Corporation: Financials

Figure 71 Whale Imaging Inc.: Financials

글로벌 심혈관 초음파 시스템 시장 – 2023-2030

Global Cardiovascular Ultrasound System Market -2023-2030